Last edited by Zolodal
Saturday, August 1, 2020 | History

1 edition of Immune-based cancer treatment found in the catalog.

Immune-based cancer treatment

Michael A. Alexander

Immune-based cancer treatment

the T lymphocyte response

by Michael A. Alexander

  • 373 Want to read
  • 25 Currently reading

Published by CRC Press, Science Publishers in Boca Raton, FL, Enfield, N.H .
Written in English

    Subjects:
  • Immunology,
  • Cancer,
  • T cells,
  • Neoplasms,
  • Immunological aspects,
  • Immunotherapy,
  • T-Lymphocytes,
  • Therapy

  • Edition Notes

    Includes bibliographical references (p. [217]-232) and index.

    StatementMichael A. Alexander
    Classifications
    LC ClassificationsRC268.3 .A435 2011
    The Physical Object
    Paginationxv, 235 p. ;
    Number of Pages235
    ID Numbers
    Open LibraryOL25136628M
    ISBN 109781578087037
    LC Control Number2010046622

    As collective knowledge of the immunological underpinnings of disease has risen, this has spurred the development and use of new, immune-based cancer therapies. While harnessing the immune system to target solid and hematologic malignancies has led to a shift in treatment paradigms, immune-related adverse effects are becoming apparent and. The culmination of 30 years of research and experience in T-cell-based cancer, this book highlights and evaluates new treatments that harness the power of the T cell to .

    Description. Cancer Immunotherapy Principles and Practice, from the Society for Immunotherapy of Cancer (SITC), is the authoritative reference on cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease.. Featuring five sections and over 50 chapters covering the Basic Principles of Tumor Immunology, Cancer Immunotherapy Targets . ew words strike as much fear into the heart as “cancer.” As too many of us know, cancer is an often cruel disease that cuts lives short and causes significant suffering for both patients and families. Compounding this fear is the fact that cancer’s treatment is often considered worse than the disease itself.

    Discussing treatment options for melanoma and the success of immunotherapy along with the challenges of immunotherapy, this book covers epidemiology, susceptibility genes, and treatment recommendations from Society for Immunotherapy of Cancer, as well as immune based therapies such as aldesleukin, Intron-A, Sylatron, Yervoy, Opdivo, Keytruda. Better understanding of human immunological system has enabled researchers to develop novel immune-based therapeutic agents for cancer. The effectiveness .


Share this book
You might also like
Parsons daughter

Parsons daughter

fortune rich Dhanna

fortune rich Dhanna

American republics and the dependent territories in the Latin American area

American republics and the dependent territories in the Latin American area

Airline Competition Enhancement Act of 1989

Airline Competition Enhancement Act of 1989

Surviving in the city

Surviving in the city

General chemistry

General chemistry

More Northerly Route

More Northerly Route

Exploring physics.

Exploring physics.

Guide to Ancient and Foreign Strokes

Guide to Ancient and Foreign Strokes

Doncaster people of ten generations ago

Doncaster people of ten generations ago

Travels in Turkey, Asia Minor, Syria and Egypt.

Travels in Turkey, Asia Minor, Syria and Egypt.

Immune-based cancer treatment by Michael A. Alexander Download PDF EPUB FB2

The culmination of 30 years of research and experience in T-cell-based cancer, this book highlights and evaluates new treatments that harness the power of the T cell to attack and kill all cancer cells in our bodies.

It describes how the T cell immune system can be manipulated and redirected to kill. Immune-based Cancer Treatment: The T Iymphocyte Response - CRC Press Book The culmination of 30 years of research and experience in T-cell-based cancer, this book highlights and evaluates new treatments that harness the power of the T cell to attack and kill all cancer cells in our bodies.

The culmination of 30 years of research and experience in T-cell-based cancer, this book highlights and evaluates new treatments that harness the power of the T cell to attack and kill all cancer cells in our bodies.

It describes how the T cell immune system can be manipulated and redirected to kill resistant cancer cells by understanding and. E-BOOK EXCERPT. Cancer Immunotherapy Principles and Practice, from the Society of Immunotherapy of Cancer (SITC), is the authoritative reference on cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease.

As well as presenting the evidence for immune-based cancer treatment, it. As well as presenting the evidence for immune-based cancer treatment, it positions immunotherapy in the context of other available cancer treatments and provides data on response rates, risks, and toxicities across a variety of diseases.

As well as presenting the evidence for immune-based cancer treatment, it positions immunotherapy in the context of other available cancer treatments and provides data on response rates, risks, and toxicities across a variety of diseases.

Filled with detailed tables, 5/5(3). ISBN: OCLC Number: Description: xv, pages ; 24 cm: Contents: Which cells control the anti-cancer T cell immune response?Antigen presentation As well as presenting the evidence for immune-based cancer treatment, it positions immunotherapy in the context of other available cancer treatments and provides data on response rates, risks, and toxicities across a variety of s: 3.

Featuring five sections and over 50 chapters covering the Basic Principles of Tumor Immunology Cancer Immunotherapy Targets and Classes Immune Function in Cancer Patients Disease-Specific Treatments and Outcomes and Regulatory Aspects of Cancer Immunotherapy this book covers all major topics that have shaped the development of immunotherapy and.

Instead of directly targeting cancer cells, immunotherapy helps the immune system better fight cancer, offering a less invasive treatment option than traditional therapy. As well as presenting the evidence for immune-based cancer treatment, it positions immunotherapy in the context of other available cancer treatments and provides data on response rates, risks, and toxicities across a variety of diseases.

This book provides basic, translational, and clinical cancer researchers an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.

Immune-based Cancer Treatment. The T Lymphocyte Response. mostly unknown to society all of these treatments are immune-based.

The purpose of this book will. Advances in cancer immunotherapy are the result of several decades of basic research, much of it supported by NCI, on how the immune system responds to cancer. Learn how NCI continues to support a wide range of research, from basic research to clinical trials, to advance the field of.

Cancer Immunotherapy Principles and Practice, from the Society for Immunotherapy of Cancer (SITC), is the authoritative reference on cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease. Identification of individuals with inherited predispositions to cancer, including Lynch syndrome, can help prevent cancer and cancer-related death by allowing for the uptake of specific cancer prevention and screening as well as the use of therapies directed toward the underlying neoplastic process for individuals with advanced cancer.

In the 25 years since the discovery of microsatellite. Cancer immunotherapy involves targeted immune-based strategies that unleash the patient's immune system to fight cancer. Over the past two decades, with the advances in our understanding of the regulation of immune responses, immunotherapy has become.

In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Immune-Based Treatment Shows Promise against Metastatic Cervical Cancer was originally published by the National Cancer Institute.”.

This book is a sum of its chapters and thus individual immunotherapies. What is not yet evident is how combinations of immune‐based therapies can be harnessed. This is undoubtedly needed in order to secure long‐term and complete treatment for the majority of malignancies, especially arising as.

Glioblastoma is one of the most aggressive solid tumors, and, despite treatment options such as surgery, radiation, and chemotherapy, its prognosis remains grim. Novel approaches are needed to improve survival. Immunotherapy has proven efficacy for melanoma, lung cancer, and kidney cancer and is now a focus for glioblastoma.

In this article, glioblastoma-mediated immunosuppression will be. Featuring five sections and over 50 chapters covering the Basic Principles of Tumor Immunology, Cancer Immunotherapy Targets and Classes, Immune Function in Cancer Patients, Disease-Specific Treatments and Outcomes, and Regulatory Aspects of Cancer Immunotherapy, this book covers all major topics that have shaped the development of.Therapeutic cancer vaccines.

The promise of immune-based therapies to control cancer has come to fruition in recent years with the regulatory approval of sipuleucel-T in prostate cancer and immune checkpoint inhibitors in melanoma (13, 14).Therapeutic cancer vaccines such as sipuleucel-T are designed to enhance immune recognition of specific TAAs, leading to immune-mediated killing of .Get this from a library!

Immune-based cancer treatment: the T lymphocyte response. [Michael A Alexander] -- The culmination of 30 years of research and experience in T-cell-based cancer, this book highlights and evaluates new treatments that harness the power of the T .